ÂÜÀòÂÒÂ×

Tyler Benedum is the Senior Vice President, Head of Chemistry, Manufacturing, and Controls (CMC) at Aktis Oncology. Prior to his time at Aktis, Tyler spent over sixteen years at Avid Radiopharmaceuticals which, during his tenure, became a wholly owned subsidiary of Eli Lilly and Company. He joined Avid in its infancy as a Research Chemist and consistently held increasing levels of responsibility from Director of Manufacturing Operations to Senior Director of Chemical Development and Manufacturing, and most recently, Vice President of CMC Development and Manufacturing. During his time at Avid, Tyler played a key role in developing and advancing AMYVID and TAUVID (both Alzheimer’s Disease positron emission tomography (PET) diagnostic imaging agents) through marketing authorization approval and commercialization.

He received a B.S. in Chemistry from Washington College and a PhD in Organic Chemistry from the University of Virginia. He then completed his Postdoctoral Fellowship in natural product synthesis at the University of Pittsburgh. During his free time, Tyler enjoys fishing and boating with his family on the Chesapeake Bay.